Investigation of patient satisfaction to Second-generation antihistamines in the treatment of Japanese cedar and cypress family pollinosis.
Not Applicable
- Conditions
- Japanese cedar and cypress family pollinosis
- Registration Number
- JPRN-UMIN000003132
- Lead Sponsor
- Department of Otorhinolaryngology , Shiga University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
(1) with nasal diseases such as nasal polyps, hypertrophic rhinitis, acute chronic rhinitis, or deviated septum which cause a barrier to evaluate nasal symptoms. (2) Patient that change of symptom is remarkable after specific immunotherapy is begun. (3) Patient who should continuously use medicine (antiallergic drugs, antihistamine drugs, anticholinergic drugs, a complex of histamine/ Gamma-globulin preparations, vasoconstrictor drugs and antihypertensive drugs) that influences when effect of drug evaluation. (5) Pregnancy, potential pregnancy, and breast-feeding patient. (6) the others, inappropriate to this study by the judgment of doctor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Transitions of nasal symptom and ocular condition of two weeks after beginning of the treatment from first medical examination
- Secondary Outcome Measures
Name Time Method Symptom score (stuffy nose,runny nose, sneezing,eye itchiness and tearing), medication score and QOL Questionaire score(JRQLQ No1). Satisfaction rating to treatment.